PDSB
PDS Biotechnology Corporation
Company Overview
| Mkt Cap | $48.97M | Price | $0.94 |
| Volume | 678.21K | Change | -1.57% |
| P/E Ratio | -1.3 | Open | $0.95 |
| Revenue | -- | Prev Close | $0.95 |
| Net Income | $-37.6M | 52W Range | $0.85 - $3.41 |
| Div Yield | N/A | Target | $7.50 |
| Overall | 52 | Value | 60 |
| Quality | -- | Technical | 45 |
No chart data available
Stock Overview
Updated DailyPDS Biotechnology Corporation (PDSB) is a leading Healthcare company in the Biotechnology industry, currently trading at $0.94 with a market capitalization of $48.97 million. The stock is approaching its 52-week lows, suggesting potential value opportunity, demonstrating unrated quality characteristics with a MarketXLS quality score of N/A.
Today's trading session shows PDSB with a volume of 678K shares. The stock opened down 0.00% from yesterday's close of $0.95. Current analyst estimates project earnings of $-0.85 per share for this year, with next year targeting $-0.74.
PDSB demonstrates weak technical indicators based on technical analysis. The company trades on the NSC exchange and operates alongside industry peers including OTIC, OTLC, OVAT-CA, ORTH-CA.
Key investment considerations for PDSB include average overall investment profile. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 702.1%. The stock shows fair valuation metrics based on valuation analysis.
Analysis generated on November 3, 2025 at 03:56 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | PDSB | $0.94 | -1.6% | 678.21K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get PDS Biotechnology Corporation Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW